Lv1
48 积分 2021-10-11 加入
Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel
1个月前
已关闭
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study
1个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
3个月前
已完结
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors
3个月前
已完结
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity
5个月前
已完结
Current advances in colorectal cancer treatment: a review of recent clinical trials
5个月前
已完结
A new first-line standard-of-care for BRAFV600E-mutated mCRC
5个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
5个月前
已完结
Current advances in colorectal cancer treatment: a review of recent clinical trials
5个月前
已完结
皖公网安备34019202002308
